Abbott Laboratories (ABT) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-3500
State of Incorp. IL
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,17010,2497,1484,1404,0869,610
Cash and cash equivalents9,8829,7996,8383,8603,8449,407
Short-term investments288450310280242203
Receivables6,2186,4876,4145,4255,1825,249
Inventory, net of allowances, customer advances and progress billings6,1735,1575,0124,3163,7963,601
Inventory6,1735,1575,0124,3163,7963,601
Disposal group, including discontinued operation     920
Other current assets      1,667
Other undisclosed current assets2,6632,3461,8671,7861,559 
Total current assets:25,22424,23920,44115,66714,63220,147
Noncurrent Assets
Operating lease, right-of-use asset 1,1161,1531,101934
Property, plant and equipment9,1628,9599,0298,0387,5637,607
Long-term investments and receivables766816821883897883
Long-term investments766816821883897883
Intangible assets, net (including goodwill)33,25335,97038,52840,22042,19645,493
Goodwill22,79923,23123,74423,19523,25424,020
Intangible assets, net (excluding goodwill)10,45412,73914,78417,02518,94221,473
Regulated entity, other noncurrent assets 71788790102119
Disposal group, including discontinued operation, noncurrent assets     17176
Other undisclosed noncurrent assets4,8463,9812,5412,0551,7661,825
Total noncurrent assets:49,21450,95752,10752,22052,54156,103
TOTAL ASSETS:74,43875,19672,54867,88767,17376,250
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13,23812,35111,6879,3858,8058,198
Interest and dividends payable831798635563489
Taxes payable306362226305309
Employee-related liabilities1,6251,4161,2371,1821,187
Accounts payable4,6074,4083,9463,2522,9752,402
Accrued liabilities8,6315,1815,1654,0353,7803,811
Debt2,2517542201,478207714
Total current liabilities:15,48913,10511,90710,8639,0128,912
Noncurrent Liabilities
Long-term debt and lease obligation14,52218,25219,42917,41619,35927,210
Long-term debt, excluding current maturities14,52217,29618,52716,66119,35927,210
Liabilities, other than long-term debt 6,5312,7383,1192,8172,0409,030
Liability, pension and other postretirement and postemployment benefits 1,7842,7383,1192,8172,040 
Other liabilities 3,804    9,030
Operating lease, liability 943956902755
Other undisclosed noncurrent liabilities9915,0775,0905,4906,040 
Total noncurrent liabilities:22,04426,06727,63825,72327,43936,240
Total liabilities:37,53339,17239,54536,58636,45145,152
Equity
Equity, attributable to parent36,68635,80232,78431,08830,52430,897
Common stock24,70924,47024,14523,85323,51223,206
Treasury stock, value(15,229)(11,822)(10,042)(10,147)(9,962)(10,225)
Accumulated other comprehensive loss(8,051)(8,374)(8,946)(8,465)(7,586)(6,062)
Retained earnings35,25731,52827,62725,84724,56023,978
Equity, attributable to noncontrolling interest219222219213198201
Total equity:36,90536,02433,00331,30130,72231,098
TOTAL LIABILITIES AND EQUITY:74,43875,19672,54867,88767,17376,250

Income Statement (P&L) ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues43,65343,07534,60831,90430,57827,390
Revenue, net27,390
Cost of revenue(19,142)(20,584)(17,135)(13,231)(12,706)(13,500)
Cost of goods and services sold(19,142)(18,537)(15,003)(13,231)(12,706)(12,337)
Gross profit:24,51122,49117,47318,67317,87213,890
Operating expenses(16,149)(14,066)(12,116)(14,141)(14,222)(12,164)
Operating income:8,3628,4255,3574,5323,6501,726
Nonoperating income5023191572782161,409
Investment income, nonoperating183434694105124
Other nonoperating income3212771031911391,251
Interest and debt expense(558)(533)(546)(733)(993)(904)
Income from continuing operations before income taxes:8,3068,2114,9684,0772,8732,231
Income tax expense(1,373)(1,140)(497)(390)(539)(1,878)
Income from continuing operations:6,9337,0714,4713,6872,334353
Income before gain (loss) on sale of properties:7,0714,4953,6872,368477
Income from discontinued operations   24 34124
Net income attributable to parent:6,9337,0714,4953,6872,368477
Other undisclosed net loss available to common stockholders, basic(28)(29)(22)(21)(15)(9)
Net income available to common stockholders, diluted:6,9057,0424,4733,6662,353468

Comprehensive Income ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income:6,9337,0714,4953,6872,368477
Other comprehensive income (loss)(341)(403)166255(47)104
Comprehensive income:6,5926,6684,6613,9422,321581
Other undisclosed comprehensive income (loss), net of tax, attributable to parent664975(647)(1,134)(1,145)948
Comprehensive income, net of tax, attributable to parent:7,2567,6434,0142,8081,1761,529

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: